Fidia Advanced Biopolymers S.r.l.

Other

Genetics Institute, Inc.

Fidia Farmaceutici S.p.a.

Anika Therapeutics S.r.l.

Deutsches Krebsforschungszentrum

Ambrosio, Luigi

Alessandra Pavesio

Lanfranco Callegaro

Andrea Pastorello

Derek T O'Hagan

John Martin Wozney

Howard Seeherman

Davide Bellini

Rebecca Li

Daniele Pressato

Hyun Kim

Marco Radice

Luigi Ambrosio

Norbert Fusenig

Hans-Jürgen Stark

Michael Willhauck

Angelo Vescovi

Lanfranco Callergaro

Massimo Dona'

Fabrizio Gelain

Gennaro Tafuri

Maurizio Verga

Anthony P Hollander

Hans-Juergen Stark

Norbert E Fusenig

Massimo Terrassan

A biomaterial for the treatment of spinal cord or of peripheral nerve injury, obtainable by:

Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

Herein described is a biocompatible material comprising a polymer matrix based on hyaluronic acid derivatives and poly-&#x3b5;Caprolactone, the process for preparing this material, a prosthetic device constituted by this biocompatible material and a reinforcing material, the process for preparing the prosthetic device, and its use for the partial or total replacement of meniscus, and regeneration of the meniscal fibrocartilage.

Biocompatible material and prosthetic device made thereof for the replacement, repair and regeneration of meniscus

The invention concerns the preparation and use of a biocompatible, biocomponent material constituted by: (a) a three-dimensional matrix of hyaluronic acid derivatives witle a structure containing empty spaces; (b) a porous, three-dimensional matrix constituted by a ceramic material; (c) possibly containing pharmacologically or biologically active ingredients.

Grafts for the repair of osteochondral defects

Compositions are provided which include hyaluronic acid derivatives in combination with vaccine antigens, and optionally adjuvants, for mucosal delivery. Also provided are methods of making the compositions, as well as methods of immunization using the same.

Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

The use in the medical-surgical field of biomaterials based on hyaluronic acid derivatives, optionally in association with natural, synthetic or semisynthetic biopolymers, for suppressing the angiogenic process associated with tumor proliferation (in primary and secondary tumors) is disclosed.

Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors

An injectable formulation is disclosed for delivery of osteogenic proteins. The formulation comprises a pharmaceutically acceptable admixture of an osteogenic protein; and formulations comprising osteogenic protein, hyaluronic acid derivatives and tricalcium phosphate are also disclosed. Methods for formulating porous injectable gels and pastes from hyaluronic acid are also disclosed.

Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins

New biomaterials essentially constituted by esterified derivatives of hyaluronic acid or by cross-linked derivatives of hyaluronic acid for use in the surgical sector, particularly for use in the prevention of post-surgical adhesions.

Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives

Disclosed is an injectable, biocompatible and biodegradable composition, comprising at least one hyaluronic acid benzyl ester or auto-cross-linked derivative, in combination with at least one mammalian cell and/or at least one pharmacologically or biologically active substance and/or micro-particles such as fibres, granules, microspheres or sponge fragments of a hyaluronic acid derivative.

Injectable hyaluronic acid derivative with pharmaceuticals/cells

Biomaterials are disclosed comprised of biodegradable, biocompatible, and bioabsorbable non-woven fabric materials for use in surgery for the guided regeneration of tissues. The non-woven fabric materials are comprised of threads embedded in a matrix, wherein both the matrix and the threads can be comprised of esters of hyaluronic acid, used singly or in combination, or esters of hyaluronic acid in combination with esters of alginic acid or other polymers.

Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells

New biomaterials essentially constituted by esterified derivatives of hyaluronic acid or by cross-linked derivatives of hyaluronic acid for use in the surgical sector, particularly for use in the prevention of post-surgical adhesion.

Growing community of inventors

Padua, Italy

Alessandra Pavesio